Peripheral Liquid Embolic Agents Market Size and Forecast (2021-2031)
Peripheral Liquid Embolic Agents Market Size and Forecast (2021 – 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Polymerizing Liquid Embolic Agent and Precipitating Liquid Embolic Agent), Application (Endoleak Type II, Malformations, Bleedings and Trauma, Varicose Vein, Tumors, Visceral Aneurysm), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
$4,152 – $7,352
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Peripheral liquid embolic agents are substances used in interventional radiology procedures to block leaking blood vessel and malformations. These agents solidify after injecting which forms plug and block the blood flow to the targeted area.
Developments in Temperature-Induced Phase Change Systems and pH-Triggered Embolic Agents Acts as a Trend for Market Growth
Liquid embolism is a topic of great interest in bioengineering, particularly in peripheral procedures. Liquid embolic agents can penetrate peripheral, nidus, or distal areas where coils or catheters cannot reach. Although currently used liquid embolic agents can meet most clinical needs, they have some shortcomings. Therefore, various novel liquid embolic agents have been developed to improve imaging characteristics, reduce complications, optimize flow performance, and achieve drug loading capability. The systematic investigation of additional important material characteristics such as associated side effects (e.g., toxicity and adhesion), biofunctional (biocompatibility, biodegradability, biomechanics, and bioactivity), and radiopacity is essential for the development of clinically tailored embolic agents in the field of minimally invasive imaging procedures.
Temperature-sensitive polymer solutions can change from a sol-injectable state to a gel state at room temperature in the body. Poly(N-isopropyl acrylamide) (PNIPAAm) exhibits a reversible phase transition in response to a lower critical solution temperature (LCST) of 32 °C. According to a study published in the Journal of Controlled Release by Qian et al. in 2015, poly(N-isopropylacrylamide-co-butylmethyl acrylate) gels with iohexol dispersions for TACE of liver cancer demonstrated effective embolization of renal arteries in rabbits and sustained release of doxorubicin. Similarly, as per a study published in the National Library of Medicine by Wang et al. in 2011, chitosan/β-glycerophosphate (C/GP) successfully closed renal arteries in rabbits, indicating to be a potential embolization agent. Likewise, Zhao et al. also investigated temperature-sensitive PNIPAAm-iohexol nano gels for embolization, according to a research study published Wiley Online Library in 2011. The hydrophobic interactions above the phase transition temperature (36.5 °C) lead to a hierarchical 3D gel network for in situ vessel casting. Compared to Lipiodol, a peripheral embolic agent, the nanogel provided better peripheral embolization in VX2 liver tumors in rabbits.
Furthermore, a poloxamer 407 (a triblock copolymer of polyethylene oxide a–polypropylene oxide b–polyethylene oxide a) containing a thermosensitive liquid embolic hydrogel has been proposed for liver cancer therapy. This composite hydrogel composed of poloxamer 407, hydroxymethyl cellulose, sodium alginate, and iodixanol (PSHI) presented two phases with increasing temperature: a flowing sol and a shrunken gel. Notably, complete occlusion of the VX2 liver cancer model was demonstrated with PSHI-Ca2+ as the tumor disappeared after embolization.
pH-sensitive active ingredients undergo a phase transition due to the pH change between the in vitro and physiological environments. These hydrogels swell and collapse in response to pH, which is used to control drug release.
As per a study published in the Royal Society of Chemistry by Nguyen et al. in 2016, PCLA-PUSSM, a copolymer consisting of poly(ε-caprolactone-co-lactide) (PCLA), PEG, and poly(urethane sulfide sulfamethazine) (PUSSM) was developed, for TACE of HCC. This biodegradable material was loaded with doxorubicin and exhibited a phase transition in response to decreasing pH. The hydrogel successfully embolized a liver tumor from a VX2 rabbit tumor model while providing a sustained release of doxorubicin. In a rat model, embolization stopped blood supply to the tumor, creating an acidic environment through hypoxia and inducing lactic acidosis. The low pH triggered drug release and successfully inhibited tumor growth in vivo.
Some of the liquid embolic agents under trial for temperature-sensitive and pH-triggered are given below:
Table 1. Liquid Embolic Agents Under Trial for Temperature-Sensitive and pH-Triggered Gelation
Liquid Embolic Agents Mechanism Advantage Classical Usage Scenarios or Trial Conditions
Chitosan/β- glycerophosphate (chitosan/β-GP) Temperature- and pH-triggered gelation Drug delivery Renal arteries in rabbits
Silk-Elastin-Like proteins (SELPs) Temperature- triggered gelation Drug delivery Primary VX2 liver tumors in rabbit
Poly(N-isopropylacrylamide-co-butyl methylacrylate) nanogel (PIB nanogel) Temperature- triggered gelation A better embolization than lipiodol Primary VX2 liver tumors in rabbit
Poloxamer 407 Temperature- triggered gelation Temporary vascular occlusion Renal arteries in canines
poloxamer 407, sodium alginate, hydroxymethyl cellulose, iodixanol, and calcium ions (PSHI-Ca2+) Temperature- triggered gelation Radiopacity Primary VX2 liver tumors in rabbit
Sulfamethazine-based hydrogel pH-triggered gelation Drug delivery Primary VX2 liver tumors in rabbit
Poly(Amino Ester Urethane) block polymer (PEAU) Temperature- and pH-triggered gelation Drug delivery Primary VX2 liver tumors in rabbit
Thus, the growing focus and developments on temperature-induced phase change systems and pH-triggered embolic agents are expected to bring new trends in the peripheral liquid embolic agents market in the coming years.
The peripheral liquid embolic agents market analysis has been carried out by considering the following segments: type, application and geography. Based on type, the peripheral liquid embolic agents market is bifurcated into polymerizing liquid embolic agents and precipitating liquid embolic agents. In terms of application, the peripheral liquid embolic agents market is classified into endoleak type II, malformations, bleedings and trauma, varicose vein, tumors, and visceral aneurysm..
The scope of the peripheral liquid embolic agents market report covers North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, Japan, India, Australia, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the biggest contributor to the global peripheral liquid embolic agents market. Asia Pacific is predicted to show the highest CAGR in the market during 2023–2031.
The North America regional market growth is attributed to the increasing cases of aneurysms, trauma, and others across the region. The market in Canada is anticipated to grow because of rising government support for addressing the increasing concerns regarding peripheral disorders. The market in Mexico is estimated to grow owing to the growing pharma industries and medical tourism. The Asia Pacific peripheral liquid embolic agents market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth in the region is driven by various factors such as the rising prevalence of peripheral artery diseases (PAD), increasing demand for minimally invasive procedures, growing number of hospitals and ambulatory surgery centers, rising focus on developing countries by market players , and developing healthcare infrastructure in Asia Pacific
Centers for Disease Control and Prevention (CDC), European Medicines Agency (EMA), The Pan American Health Organization (PAHO), and World Health Organization (WHO) are a few key primary and secondary sources referred to while preparing the report on the peripheral liquid embolic agents market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to our latest study on “Peripheral Liquid Embolic Agents Market Forecast to 2031 –Global Analysis – Type and Application” the market is expected to grow from US$ 40.42 million in 2023 and is expected to reach US$ 81.41 million by 2031; it is anticipated to record a CAGR of 9.1% from 2023 to 2031. The report highlights the key factors driving the peripheral liquid embolic agents market growth and prominent players with their developments in the market.
The peripheral liquid embolic agents market analysis has been carried out by considering the following segments: type, application and geography.
Based on type, the peripheral liquid embolic agents market is bifurcated into polymerizing liquid embolic agents and precipitating liquid embolic agents. The precipitating liquid embolic agent segment held the largest market share in 2023. Precipitants are combined with a solvent. After dilution in the blood, the polymer precipitates, and the mechanism of action is similar to that of ethylene vinyl alcohol (EVOH). EVOH is a copolymer with a dimethyl sulfoxide (DMSO) solvent and a suspension of (radiopaque) micronized tantalum powder. When injected through a catheter and mixed with blood, the solvent is diluted, causing the copolymer to precipitate into a spongy plaster with a gel-like consistency, resulting in vascular occlusion at a slower rate than glue. Onyx has been used to embolize arteriovenous malformations (AVMs). Other applications include embolization of visceral aneurysms/pseudoaneurysms, endoleaks, portal vein embolization, and end-organ embolization, such as renal angiomyolipomas (AML). Poly(2-hydroxyethyl methacrylate) or pHEMA is a biocompatible, hydrophilic, optically transparent, and non-degradable polymer. pHEMA has been used in various biomedical applications over the years, owing to advances in research and development. These applications include soft contact lenses, ocular drug delivery and controlled drug delivery systems, bone tissue regeneration, artificial corneas, artificial skin, breast augmentation, catheters, wound dressings, intrauterine inserts, and prostheses. Onyx (Medtronic, Dublin, Ireland) is an example of a currently available precipitant. Squid (Emboflu, Gland, Switzerland), precipitating hydrophobic injectable liquid (PHIL; Terumo Medical), Easyx (Antia Therapeutics AG, Bern, Switzerland), Lava (Black Swan Vascular Inc, Hayward, CA), and others are available in various concentrations.
In terms of application, the peripheral liquid embolic agents market is classified into endoleak type II, malformations, bleedings and trauma, varicose vein, tumors and visceral aneurysm. The endoleak type II segment held the largest market share in 2023. Type II endoleak (T2E) is the retrograde filling of the aneurysm sac by open aortic branch vessels, usually lumbar or inferior mesenteric arteries. T2E is the most common complication after endovascular aneurysm repair (EVAR). There is a shift toward liquid emboli, particularly NBC (N-butyl cyanoacrylate) and EVOH-based liquids such as Onyx (Onyx LES, Covidien), which are most commonly used. Iodized liquid polyvinyl alcohol (PVA) polymer agent (EASYX, Qmedics AG) with CE approval for peripheral use consists of a PVA polymer in liquid form that forms a solid cast when the solvent (DMSO) comes into contact with the blood circulation dissolves. This liquid agent has no adhesive properties and is covalently bound to iodine, which gives it its intrinsic opacity. Better understanding of the type II endoleak circuit regarding inflow and outflow vessels has led to greater accomplishments in embolization techniques.
The scope of the peripheral liquid embolic agents market report covers North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, Japan, India, Australia, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the biggest contributor to the global peripheral liquid embolic agents market. Asia Pacific is predicted to show the highest CAGR in the market during 2023–2031. The Asia Pacific peripheral liquid embolic agents market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth in the region is driven by various factors such as the rising prevalence of peripheral artery diseases (PAD), increasing demand for minimally invasive procedures, growing number of hospitals and ambulatory surgery centers, rising focus on developing countries by market players , and developing healthcare infrastructure in Asia Pacific.
China, as a significant low- and middle-income country, faces the challenge of the PAD burden as the country’s economic expansion. According to the Journal of Vascular Surgery, in China, the total number of people affected by PAD is estimated to have increased by 40% from 2000 to 2020. China has the largest population with type 2 diabetes mellitus (T2DM). Type 2 diabetes affects over 116 million adults in China, and estimates predict that this number will rise to 147 million by 2045. People affected by type 2 diabetes are 1.5 to 4.0 times more likely to develop PAD than non-diabetic people. In China, the prevalence of PAD in diabetic patients has been reported to be between 6% and 10%. However, the lack of awareness and lower treatment and control rates for PAD and its risk factors in China may be the reason for the higher prevalence of PAD in women than in men, as well as the sharp increase in PAD cases after the mid-1960s. In addition, the robust healthcare infrastructure in the country is facilitating the adoption of advanced technologies. Market players are engaged in strategic activities to expand their footprint in the market. In May 2021, Grand Pharmaceutical and Healthcare Holdings Limited acquired Shenming Medical Technology Co., Ltd. The company obtained all rights of an innovative thermosensitive embolic agent that is used for liver cancer treatment, further expanding the tumor intervention treatment product pipeline.
The peripheral liquid embolic agents market growth in Japan is primarily attributed to the rising prevalence of PAD. The geriatric population is more prone to developing various health-related issues. According to the World Economic Forum, in 2023, more than 10% of Japan’s population was 80 or above, that is almost a third of the entire population (~36.23 million) was aged 65 and above. As per the Ministry of Internal Affairs Communications, 29.1% of the population in Japan is of elderly people aged 65 years and above. Furthermore, Japan is technologically advanced and has many companies that provide the best treatment devices and contribute to better healthcare facilities.
Medtronic, B Braun SE, Guerbet SA, Sirtex Medical Ltd, Balt, MicroVention Inc, Johnson & Johnson, and GEM srl are among the leading companies operating in the global peripheral liquid embolic agents market.
Companies operating in the peripheral liquid embolic agents market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the peripheral liquid embolic agents market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall peripheral liquid embolic agents market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the peripheral liquid embolic agents market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth market trends and outlook coupled with the factors driving the peripheral liquid embolic agents market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Peripheral Liquid Embolic Agents Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Regional Pricing Analysis, 2023
5. Peripheral Liquid Embolic Agents Market – Key Market Dynamics
5.1 Peripheral Liquid Embolic Agents Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Incidence of Peripheral Vascular Diseases
5.2.2 Increasing Demand for Minimally Invasive Procedures
5.3 Market Restraints
5.3.1 High Cost of Embolization Agents
5.4 Market Opportunities
5.4.1 Growing Strategic Initiatives by Market Players
5.5 Future Trends
5.5.1 Developments in Temperature-Induced Phase Change Systems and pH-Triggered Embolic Agents
5.6 Impact analysis
6. Peripheral Liquid Embolic Agents Market – Global Market Analysis
6.1 Peripheral Liquid Embolic Agents Market Revenue (US$ Thousand), 2021–2031
6.2 Peripheral Liquid Embolic Agents Market Analysis
6.3 Market Positioning Analysis, 2023
7. Peripheral Liquid Embolic Agents Market Analysis – by Type
7.1 Polymerizing Liquid Embolic Agent
7.1.1 Overview
7.1.2 Polymerizing Liquid Embolic Agent: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
7.2 Precipitating Liquid Embolic Agent
7.2.1 Overview
7.2.2 Precipitating Liquid Embolic Agent: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
8. Peripheral Liquid Embolic Agents Market Analysis – by Application
8.1 Endoleak Type II
8.1.1 Overview
8.1.2 Endoleak Type II: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
8.2 Malformations
8.2.1 Overview
8.2.2 Malformations: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
8.3 Bleedings and Trauma
8.3.1 Overview
8.3.2 Bleedings and Trauma: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
8.4 Varicose Vein
8.4.1 Overview
8.4.2 Varicose Vein: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
8.5 Tumours
8.5.1 Overview
8.5.2 Tumours: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
8.6 Visceral Aneurysm
8.6.1 Overview
8.6.2 Visceral Aneurysm: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9. Peripheral Liquid Embolic Agents Market – Geographical Analysis
9.1 North America
9.1.1 North America Peripheral Liquid Embolic Agents Market Overview
9.1.2 North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.1.2.1 North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Type
9.1.2.2 North America: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Type
9.1.2.2.1 North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Polymerizing Liquid Embolic Agent
9.1.2.2.2 North America: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Polymerizing Liquid Embolic Agent
9.1.2.2.3 North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Precipitating Liquid Embolic Agent
9.1.2.2.4 North America: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Precipitating Liquid Embolic Agent
9.1.2.3 North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Application
9.1.3 North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Country
9.1.3.1 Canada: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.1.3.1.1 Canada: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.1.3.1.1.1 Canada: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.1.3.1.1.2 Canada: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.1.3.1.2 Canada: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.1.3.2 Mexico: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.1.3.2.1 Mexico: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.1.3.2.1.1 Mexico: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.1.3.2.1.2 Mexico: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.1.3.2.2 Mexico: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.2 Europe
9.2.1 Europe Peripheral Liquid Embolic Agents Market Overview
9.2.2 Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.2.1 Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Type
9.2.2.2 Europe: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Type
9.2.2.2.1 Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Polymerizing Liquid Embolic Agent
9.2.2.2.2 Europe: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Polymerizing Liquid Embolic Agent
9.2.2.2.3 Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Precipitating Liquid Embolic Agent
9.2.2.2.4 Europe: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Precipitating Liquid Embolic Agent
9.2.2.3 Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Application
9.2.3 Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Country
9.2.3.1 Germany: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.1.1 Germany: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.2.3.1.1.1 Germany: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.2.3.1.1.2 Germany: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.2.3.1.2 Germany: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.2.3.2 United Kingdom: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.2.1 United Kingdom: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.2.3.2.1.1 United Kingdom: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.2.3.2.1.2 United Kingdom: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.2.3.2.2 United Kingdom: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.2.3.3 France: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.3.1 France: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.2.3.3.1.1 France: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.2.3.3.1.2 France: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.2.3.3.2 France: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.2.3.4 Italy: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.4.1 Italy: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.2.3.4.1.1 Italy: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.2.3.4.1.2 Italy: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.2.3.4.2 Italy: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.2.3.5 Spain: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.5.1 Spain: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.2.3.5.1.1 Spain: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.2.3.5.1.2 Spain: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.2.3.5.2 Spain: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.2.3.6 Rest of Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.6.1 Rest of Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.2.3.6.1.1 Rest of Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.2.3.6.1.2 Rest of Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.2.3.6.2 Rest of Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.3 Asia Pacific
9.3.1 Asia Pacific Peripheral Liquid Embolic Agents Market Overview
9.3.2 Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.2.1 Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Type
9.3.2.2 Asia Pacific: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Type
9.3.2.2.1 Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Polymerizing Liquid Embolic Agent
9.3.2.2.2 Asia Pacific: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Polymerizing Liquid Embolic Agent
9.3.2.2.3 Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Precipitating Liquid Embolic Agent
9.3.2.2.4 Asia Pacific: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Precipitating Liquid Embolic Agent
9.3.2.3 Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Application
9.3.3 Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Country
9.3.3.1 China: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.1.1 China: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.3.3.1.1.1 China: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.3.3.1.1.2 China: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.3.3.1.2 China: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.3.3.2 Japan: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.2.1 Japan: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.3.3.2.1.1 Japan: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.3.3.2.1.2 Japan: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.3.3.2.2 Japan: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.3.3.3 India: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.3.1 India: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.3.3.3.1.1 India: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.3.3.3.1.2 India: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.3.3.3.2 India: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.3.3.4 Australia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.4.1 Australia: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.3.3.4.1.1 Australia: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.3.3.4.1.2 Australia: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.3.3.4.2 Australia: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.3.3.5 South Korea: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.5.1 South Korea: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.3.3.5.1.1 South Korea: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.3.3.5.1.2 South Korea: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.3.3.5.2 South Korea: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.3.3.6 Rest of APAC: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.6.1 Rest of APAC: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.3.3.6.1.1 Rest of APAC: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.3.3.6.1.2 Rest of APAC: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.3.3.6.2 Rest of APAC: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.4 Middle East & Africa
9.4.1 Middle East & Africa Peripheral Liquid Embolic Agents Market Overview
9.4.2 Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.4.2.1 Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Type
9.4.2.2 Middle East & Africa: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Type
9.4.2.2.1 Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Polymerizing Liquid Embolic Agent
9.4.2.2.2 Middle East & Africa: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Polymerizing Liquid Embolic Agent
9.4.2.2.3 Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Precipitating Liquid Embolic Agent
9.4.2.2.4 Middle East & Africa: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Precipitating Liquid Embolic Agent
9.4.2.3 Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Application
9.4.3 Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Country
9.4.3.1 Saudi Arabia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.4.3.1.1 Saudi Arabia: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.4.3.1.1.1 Saudi Arabia: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.4.3.1.1.2 Saudi Arabia: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.4.3.1.2 Saudi Arabia: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.4.3.2 South Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.4.3.2.1 South Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.4.3.2.1.1 South Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.4.3.2.1.2 South Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.4.3.2.2 South Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.4.3.3 United Arab Emirates: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.4.3.3.1 United Arab Emirates: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.4.3.3.1.1 United Arab Emirates: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.4.3.3.1.2 United Arab Emirates: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.4.3.3.2 United Arab Emirates: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.4.3.4 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.4.3.4.1 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.4.3.4.1.1 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.4.3.4.1.2 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.4.3.4.2 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.5 South and Central America
9.5.1 South and Central America Peripheral Liquid Embolic Agents Market Overview
9.5.2 South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.5.2.1 South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Type
9.5.2.2 South and Central America: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Type
9.5.2.2.1 South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Polymerizing Liquid Embolic Agent
9.5.2.2.2 South and Central America: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Polymerizing Liquid Embolic Agent
9.5.2.2.3 South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Precipitating Liquid Embolic Agent
9.5.2.2.4 South and Central America: Peripheral Liquid Embolic Agents Market – Volume and Forecast Analysis – by Precipitating Liquid Embolic Agent
9.5.2.3 South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Application
9.5.3 South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast Analysis – by Country
9.5.3.1 Brazil: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.5.3.1.1 Brazil: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.5.3.1.1.1 Brazil: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.5.3.1.1.2 Brazil: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.5.3.1.2 Brazil: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.5.3.2 Argentina: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.5.3.2.1 Argentina: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.5.3.2.1.1 Argentina: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.5.3.2.1.2 Argentina: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.5.3.2.2 Argentina: Peripheral Liquid Embolic Agents Market Breakdown, by Application
9.5.3.3 Rest of South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
9.5.3.3.1 Rest of South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Type
9.5.3.3.1.1 Rest of South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
9.5.3.3.1.2 Rest of South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
9.5.3.3.2 Rest of South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Application
10. Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Peripheral Liquid Embolic Agents Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Medtronic Plc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 B Braun SE
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Guerbet SA
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Sirtex Medical Ltd
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Balt
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 MicroVention Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Johnson & Johnson
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 GEM srl
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About the Research Team
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Peripheral Liquid Embolic Agents Market Segmentation
Table 2. Regional Pricing Analysis, Price (US$)/ML, 2023
Table 3. Liquid Embolic Agents Under Trial for Temperature-Sensitive and pH-Triggered Gelation
Table 4. Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 5. Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 6. North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 7. North America: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Type
Table 8. North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 9. North America: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Polymerizing Liquid Embolic Agent
Table 10. North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 11. North America: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Precipitating Liquid Embolic Agent
Table 12. North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 13. Canada: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 14. Canada: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 15. Canada: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 16. Canada: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 17. Mexico: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 18. Mexico: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 19. Mexico: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 20. Mexico: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 21. Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 22. Europe: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Type
Table 23. Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 24. Europe: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Polymerizing Liquid Embolic Agent
Table 25. Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 26. Europe: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Precipitating Liquid Embolic Agent
Table 27. Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 28. Germany: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 29. Germany: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 30. Germany: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 31. Germany: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 32. United Kingdom: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 33. United Kingdom: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 34. United Kingdom: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 35. United Kingdom: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 36. France: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 37. France: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 38. France: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 39. France: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 40. Italy: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 41. Italy: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 42. Italy: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 43. Italy: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 44. Spain: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 45. Spain: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 46. Spain: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 47. Spain: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 48. Rest of Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 49. Rest of Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 50. Rest of Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 51. Rest of Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 52. Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 53. Asia Pacific: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Type
Table 54. Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 55. Asia Pacific: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Polymerizing Liquid Embolic Agent
Table 56. Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 57. Asia Pacific: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Precipitating Liquid Embolic Agent
Table 58. Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 59. China: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 60. China: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 61. China: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 62. China: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 63. Japan: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 64. Japan: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 65. Japan: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 66. Japan: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 67. India: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 68. India: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 69. India: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 70. India: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 71. Australia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 72. Australia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 73. Australia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 74. Australia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 75. South Korea: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 76. South Korea: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 77. South Korea: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 78. South Korea: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 79. Rest of APAC: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 80. Rest of APAC: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 81. Rest of APAC: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 82. Rest of APAC: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 83. Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 84. Middle East & Africa: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Type
Table 85. Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 86. Middle East & Africa: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Polymerizing Liquid Embolic Agent
Table 87. Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 88. Middle East & Africa: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Precipitating Liquid Embolic Agent
Table 89. Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 90. Saudi Arabia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 91. Saudi Arabia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 92. Saudi Arabia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 93. Saudi Arabia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 94. South Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 95. South Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 96. South Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 97. South Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 98. United Arab Emirates: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 99. United Arab Emirates: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 100. United Arab Emirates: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 101. United Arab Emirates: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 102. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 103. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 104. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 105. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 106. South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 107. South and Central America: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Type
Table 108. South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 109. South and Central America: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Polymerizing Liquid Embolic Agent
Table 110. South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 111. South and Central America: Peripheral Liquid Embolic Agents Market – Volume and Forecast to 2031(ML) – by Precipitating Liquid Embolic Agent
Table 112. South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 113. Brazil: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 114. Brazil: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 115. Brazil: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 116. Brazil: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 117. Argentina: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 118. Argentina: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 119. Argentina: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 120. Argentina: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 121. Rest of South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 122. Rest of South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Polymerizing Liquid Embolic Agent
Table 123. Rest of South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Precipitating Liquid Embolic Agent
Table 124. Rest of South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand) – by Application
Table 125. Recent Inorganic Growth Strategies in the Peripheral Liquid Embolic Agents Market
Table 126. Recent Organic Growth Strategies in the Peripheral Liquid Embolic Agents Market
Table 127. Glossary of Terms, Peripheral Liquid Embolic Agents Market
LIST OF FIGURES
Figure 1. Peripheral Liquid Embolic Agents Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Peripheral Liquid Embolic Agents Market Revenue (US$ Thousand), 2021–2031
Figure 5. Manufacturers Market Positioning, 2023
Figure 6. Peripheral Liquid Embolic Agents Market Share (%) – by Type (2023 and 2031)
Figure 7. Polymerizing Liquid Embolic Agent: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 8. Precipitating Liquid Embolic Agent: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 9. Peripheral Liquid Embolic Agents Market Share (%) – by Application (2023 and 2031)
Figure 10. Endoleak Type II: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 11. Malformations: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 12. Bleedings and Trauma: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 13. Varicose Vein: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 14. Tumours: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 15. Visceral Aneurysm: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 16. North America Peripheral Liquid Embolic Agents Market by Key Countries, 2023
Figure 17. North America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 18. North America: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 19. Canada: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 20. Mexico: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 21. Europe Peripheral Liquid Embolic Agents Market by Key Countries, 2023
Figure 22. Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 23. Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 24. Germany: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 25. United Kingdom: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 26. France: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 27. Italy: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 28. Spain: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 29. Rest of Europe: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 30. Asia Pacific Peripheral Liquid Embolic Agents Market by Key Countries, 2023
Figure 31. Asia Pacific: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 32. Asia Pacific: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 33. China: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 34. Japan: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 35. India: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 36. Australia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 37. South Korea: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 38. Rest of APAC: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 39. Middle East & Africa Peripheral Liquid Embolic Agents Market by Key Countries, 2023
Figure 40. Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 41. Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 42. Saudi Arabia: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 43. South Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 44. United Arab Emirates: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 45. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 46. South & Central America Peripheral Liquid Embolic Agents Market by Key Countries, 2023
Figure 47. South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 48. South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 49. Brazil: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 50. Argentina: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 51. Rest of South and Central America: Peripheral Liquid Embolic Agents Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 52. Growth Strategies in the Peripheral Liquid Embolic Agents Market
The List of Companies – Peripheral Liquid Embolic Agents Market
o Medtronic
o B Braun SE
o Guerbet SA
o Sirtex Medical Ltd
o Balt
o MicroVention Inc
o Johnson & Johnson
o GEM srl
You must be logged in to post a review.
Reviews
There are no reviews yet.